missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ NDUFAF4 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA550713
This item is not returnable.
View return policy
Description
The antibody detects endogenous levels of total NDUFAF4 protein.
NADH:ubiquinone oxidoreductase (complex I) catalyzes the transfer of electrons from NADH to ubiquinone (coenzyme Q) in the first step of the mitochondrial respiratory chain, resulting in the translocation of protons across the inner mitochondrial membrane. This gene encodes a complex I assembly factor. Mutations in this gene are a cause of mitochondrial complex I deficiency.
Specifications
| NDUFAF4 | |
| Polyclonal | |
| Unconjugated | |
| NDUFAF4 | |
| 1110007M04Rik; 3000003G13Rik; AW214064; bA22L21.1; C6orf66; hormone-regulated proliferation associated protein 20; hormone-regulated proliferation-associated 20 kDa protein; hormone-regulated proliferation-associated protein of 20 kDa; Hormone-regulated proliferation-associated protein of 20 kDa homolog; hormone-regulated proliferation-associated protein, 20 kDa; Hrpap20; HSPC125; My013; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 4; NADH dehydrogenase (ubiquinone) complex I, assembly factor 4; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4; NADH:ubiquinone oxidoreductase complex assembly factor 4; Ndufaf4; Protein HRPAP20 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 29078 | |
| -20°C | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 2.8 mg/mL | |
| PBS with 40% glycerol and 0.05% sodium azide; pH 7.4 | |
| Q9P032 | |
| NDUFAF4 | |
| Synthetic peptide corresponding to residues near the C terminal of human NADH dehydrogenase (ubiquinone) complex I, assembly factor 4. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction